Article
Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection.
Future microbiology - 1 Jan 2015
Sluis-Cremer Nicolas, Wainberg Mark A, Schinazi Raymond F
Abstract excerpt
Inhibitors that target the retroviral enzyme reverse transcriptase (RT) have played an indispensable role in the treatment and prevention of HIV-1 infection. They can be grouped into two distinct therapeutic groups, namely the nucleoside and nucleotide RT inhibitors (NRTIs), and the non-nucleoside RT inhibitors (NNRTIs). NRTIs form the backbones of most first- and second-line antiretroviral therapy (ART) regimens...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
